Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 12,667	$ 35,896
Accounts receivable	6,500	7,718
Prepaid expense and other current assets	3,250	6,500
Total current assets	22,417	50,114
Patents and trademarks, net	146,329	150,130
Total assets	168,746	200,244
Current liabilities
Accounts payable and accrued liabilities	952,243	865,497
Accounts payable related party	500	7,616
Accrued interest payable	1,140,282	1,021,373
Derivative liability	40,471
Loans from related party	52,499	52,499
Notes payable	552,000	552,000
Convertible notes payable	220,000	220,000
Total current liabilities	2,957,995	2,718,985
Convertible notes payable related party, net of unamortized discount of $2,447,770 and $3,060,970 respectively	1,939,902	1,787,439
Convertible notes payable, net of unamortized debt discount of $203,476 and $54,450, respectively, less current portion	161,133	148,599
Total liabilities	5,059,030	4,655,023
Stockholders' deficit
Common stock; $0.001 par value; 200,000,000 shares authorized; 4,539,843 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	4,540	4,540
Shares payable
Additional paid-in capital	30,241,089	30,241,089
Accumulated deficit	(35,135,913)	(34,700,408)
Total stockholders' deficit	(4,890,284)	(4,454,779)
Total liabilities and stockholders' deficit	$ 168,746	$ 200,244